1)日本ポリープ状脈絡膜血管症研究会:ポリープ状脈絡膜血管症の診断基準.日眼会誌 109:417-427,2005
2)Marano F, Deutman AF, Leys A et al:Hereditary retinal dystrophies and choroidal neovascularization. Graefes Arch Clin Exp Ophthalmol 238:760-764, 2000
3)川越直顕・高橋政代・万代道子・他:peripherin/RDS遺伝子異常による網膜変性に脈絡膜新生血管を認めた症例.日眼会誌 111:336-342,2007
4)岩切 亮・沖波 聡・平田 憲:脈絡膜新生血管を合併した網膜色素変性の2例.日眼会誌 111:606-611,2007
mutation(P391H)in 2 siblings with Oguchi disease with markedly reduced cone responses. Ophthalmology 114:134-141, 2007
6)Pagon RA:Retinitis pigmentosa. Surv Ophthalmol 33:137-177, 1988
gene. Invest Ophthalmol Vis Sci 44:3570-3577, 2003
8)Francis PJ, Schultz DW, Gregory AM et al:Genetic and phenotypic heterogeneity in pattern dystrophy. Br J Ophthalmol 89:1115-1119, 2005
gene. Prog Retin Eye Res 27:213-235, 2008
10)Tano Y:Guidelines for PDT in Japan. Ophthalmology 115:585-585 e586, 2008
11)Yoon JU, Byun YJ, Koh HJ:Intravitreal anti-VEGF versus photodynamic therapy with verteporfin for treatment of myopic choroidal neovascularization. Retina 30:418-424, 2010
12)Ikuno Y, Nagai Y, Matsuda S et al:Two-year visual results for older Asian women treated with photodynamic therapy or bevacizumab for myopic choroidal neovascularization. Am J Ophthalmol 149:140-146, 2010